Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 2,179 shares at $78.53 ($171K) on 2013-09-03, disclosed to the SEC on 2013-09-04.
Scheduled sale ($171k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.53 | 1,979 | $155K | 90.8% |
| 2 | $79.19 | 200 | $16K | 9.2% |
| Total | $78.59 avg | 2,179 | $171K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |